| Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor studied in …STUDIED_INderived200 of 253show all (up to 200) |
|---|
| → studied in | NCT06441331Phase 1 · recruiting Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194044Phase 1 · recruiting Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297979Phase 1 · recruiting Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926283Phase 1 · recruiting A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830667Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Childhood Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06395103Phase 1/Phase 2 · recruiting Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695311Phase 1 · not yet recruiting EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03715933Phase 1 · recruiting Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06156410Phase 1 · recruiting Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465199Phase 1/Phase 2 · recruiting Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918640Phase 1/Phase 2 · recruiting Lurbinectedin in FET-Fused Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03356782Phase 1/Phase 2 · not yet recruiting Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04433221Phase 1/Phase 2 · not yet recruiting Combination Immunotherapy Targeting Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781891Phase 2 · not yet recruiting RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946529Phase 2 · completed Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05395741Phase 1/Phase 2 · completed Regorafenib in Patients With Refractory Primary Bone Tumors · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05968768Phase 2 · recruiting To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820957Phase 2/Phase 3 · active not recruiting Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514819NA · recruiting Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02243605Phase 2 · active not recruiting Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172958Phase 1 · recruiting Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628634early Phase 1 · recruiting Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337177Phase 1 · active not recruiting Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306161Phase 3 · active not recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725783recruiting Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389244Phase 2 · completed A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796543NA · recruiting Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07321912Phase 2 · recruiting Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635632Phase 1 · active not recruiting C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07685405recruiting Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06571734Phase 2 · recruiting XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840047Phase 2 · active not recruiting Methionine PET/CT Studies In Patients With Cancer · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188532NA · recruiting Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07197554Phase 1 · recruiting A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620431not yet recruiting Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06068075NA · active not recruiting Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094101Phase 1/Phase 2 · recruiting Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864109Phase 2 · active not recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03442465recruiting Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04308330Phase 1 · recruiting Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440786Phase 2 · active not recruiting CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516353NA · not yet recruiting my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06566092Phase 1 · active not recruiting Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02945800Phase 2 · completed Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05046314Phase 2 · completed A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03478462Phase 1 · active not recruiting Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07048249early Phase 1 · recruiting Single Arm Romiplostim to Prevent CIT · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04890093Phase 1/Phase 2 · suspended Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05033288recruiting Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00186992Phase 2 · active not recruiting Radiation Therapy to Treat Musculoskeletal Tumors · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06709495Phase 1/Phase 2 · recruiting Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055220NA · recruiting Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222735Phase 1 · recruiting Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625351Phase 1 · completed A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06387485NA · recruiting A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415816NA · completed Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734066Phase 1/Phase 2 · recruiting Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05779670recruiting Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231906Phase 3 · completed Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Extraskeletal Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05071209Phase 1/Phase 2 · active not recruiting Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995003Phase 1 · recruiting HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05830084Phase 1 · active not recruiting Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04845893recruiting Observational Study on Skeletal Ewing's Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858168Phase 1 · completed Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067115Phase 1/Phase 2 · completed SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03011528Phase 2 · completed First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3) · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162732NA · completed Molecular-Guided Therapy for Childhood Cancer · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03514407Phase 1 · terminated A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02508038Phase 1 · recruiting Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215728completed Machine Learning Applied to EHRs Data of Patients With Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05182164Phase 2 · recruiting Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671693NA · active not recruiting A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07141862recruiting Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605522Phase 1 · terminated A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05275426Phase 2 · completed A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07092306Phase 2 · not yet recruiting A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06659224completed The Risk of Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066982Phase 1/Phase 2 · recruiting Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530487Phase 2 · terminated Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03842865temporarily not available Expanded Access of Vigil in Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06827717Phase 2 · recruiting Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05062707recruiting Early Ageing During Therapy in AYA Cancer Patients · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898755completed Collecting and Storing Tissue From Young Patients With Cancer · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05772312completed Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02100891Phase 2 · terminated Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03496402NA · active not recruiting Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06243588recruiting Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06851221NA · completed Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06850506active not recruiting Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03778996Phase 2 · active not recruiting SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03190174Phase 1/Phase 2 · completed Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657005Phase 1/Phase 2 · terminated TK216 in Patients With Relapsed or Refractory Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586104NA · completed Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03373097Phase 1/Phase 2 · active not recruiting Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03709680Phase 2 · active not recruiting Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076906Phase 1 · completed MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04791228Phase 2 · withdrawn A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05302921Phase 2 · completed Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06699472Phase 2 · recruiting A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029218NA · recruiting Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604783Phase 1 · terminated Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06564272Phase 2 · recruiting A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04129151Phase 2 · terminated Palbociclib + Ganitumab In Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Extraskeletal Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06451302NA · active not recruiting Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05093322Phase 1/Phase 2 · completed A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02624388Phase 2 · terminated Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06340204Phase 1 · recruiting Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024253Phase 3 · completed Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01661400Phase 1 · completed Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01336803Phase 2 · completed Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03458728Phase 1/Phase 2 · terminated Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600649Phase 1 · unknown Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02736565Phase 1 · completed Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019578Phase 1 · completed Stereotactic Radiosurgery in Treating Patients With Brain Tumors · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05328258Phase 3 · recruiting Use of GnRHa During Chemotherapy for Fertility Protection · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02644460Phase 1 · completed Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02304458Phase 1/Phase 2 · completed Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00899990completed Collecting and Storing Biological Samples From Patients With Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02536183Phase 1 · terminated A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04854018Phase 4 · completed Indo-cyanine Green (ICG) in Paediatric Oncology MIS · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04735289unknown Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04758000Phase 2 · recruiting Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266196Phase 1/Phase 2 · unknown A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05100368completed The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03542097completed Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03495921Phase 3 · terminated A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730349Phase 1/Phase 2 · terminated A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890758Phase 1 · completed Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04661852Phase 1 · completed Cabozantinib With Topotecan-Cyclophosphamide · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04956198completed Drug Sensitivity and Mutation Profiling · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02511132Phase 2 · completed A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03359005Phase 2 · unknown Irinotecan and Temozolomide for Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03441360Phase 2 · completed Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02063022Phase 3 · completed Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727387Phase 2 · completed Protocol for the Treatment of Metastatic Ewing Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03245450Phase 1/Phase 2 · completed Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03275818Phase 2 · completed Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013336Phase 1 · unknown Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01061840Phase 1 · completed Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05042934Phase 1/Phase 2 · withdrawn Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02982941Phase 1 · completed Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116800Phase 2 · withdrawn Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222767Phase 2 · completed Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01217437Phase 2 · completed Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02581384Phase 1/Phase 2 · terminated Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02116777Phase 1/Phase 2 · completed Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044120Phase 1 · completed ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520128NA · completed A Study of IMRT in Primary Bone and Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03880123Phase 1 · withdrawn Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159443completed Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026780completed Eligibility Screening for a NCI Pediatric Oncology Branch Research Study · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001686completed Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01331135Phase 1 · completed Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154816Phase 2 · completed Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390843Phase 1 · completed Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038142Phase 2 · terminated Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03968471completed Chemotherapy-induced Necrosis in Ewing Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962103Phase 1/Phase 2 · completed Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339898completed Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00428272Phase 1 · terminated HGS-ETR2 to Treat Children With Solid Tumors · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856048Phase 2/Phase 3 · unknown Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001564Phase 2 · completed A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004853Phase 1 · completed Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00987636Phase 3 · completed Study in Localized and Disseminated Ewing Sarcoma · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689336Phase 2 · withdrawn Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02546544Phase 2 · completed Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02409576Phase 1/Phase 2 · unknown Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03029481no longer available Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02557854Phase 1 · withdrawn HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03416517Phase 1/Phase 2 · unknown Anlotinib and Irinotecan for Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01286987Phase 1 · completed Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00464620Phase 2 · completed Trial of Dasatinib in Advanced Sarcomas · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807468Phase 2 · unknown Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors · condition mapped ONTOLOGY_EXACT · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070109Phase 2 · completed Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors · condition mapped CURATED_BROADER · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00617890Phase 2 · terminated A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720) · condition mapped ALIAS · 253 trials mapped (92 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |